Tal Medical is a clinical stage neuroscience company pioneering non-invasive neuromodulation treatments for brain disorders.
We aim to redefine the clinical paradigm in neuropsychiatry by introducing a safe, at-home treatment modality into mainstream clinical practice.
Our lead platform, Low Field Magnetic Stimulation (LFMS), has been tested in five randomized, controlled clinical studies in depression to date.
These studies have shown rapid antidepressant effect in patients who did not respond to prior drug treatment, without any major side effects.
If our planned pivotal study confirms LFMS’ rapid antidepressant effect, LFMS could transform the way we treat depression, and become one of the most important innovations in the treatment of brain disorders.